Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to ...
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks -- including ...
Morning Overview on MSN
The FDA cleared Xocova, the first oral antiviral to prevent COVID-19 after exposure, in a five-day pill course shown to cut infections in a phase 3 trial
Households where someone tests positive for COVID-19 now have an oral drug option to protect the people around them. The FDA ...
As the summer surge of COVID-19 crests, many people are weighing whether they need to get booster shots now to protect against the disease (SN: 7/19/24). The U.S. Food and Drug Administration approved ...
The Food and Drug Administration approved an updated coronavirus vaccine manufactured by Novavax Friday, days after new mRNA coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna started ...
Bangkok Post on MSN
Minister allays fears over new COVID-19 variant
Public Health Minister Pattana Promphat yesterday said there is no need to panic over the new Covid-19 variant, as there are ...
Coronaviruses not only use the machinery of the human cells they infect: they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly. This is the main ...
Mutating virus variant and cell mutation variants as a health risk concept and new coronavirus outbreak or covid-19 viral cells mutations and influenza background as a 3D render.[FILE} The Covid-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results